Notice of Results and Investor Presentation
21/02/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230221:nRSU4862Qa&default-theme=true
RNS Number : 4862Q Quixant PLC 21 February 2023
21 February 2023
Quixant plc
("Quixant" or the "Group")
Notice of Results and Presentations
Quixant (AIM:QXT), a leading provider of innovative, highly engineered
technology products principally for the global gaming and broadcast
industries, confirms that it expects to announce its results for the year
ended 31 December 2022 on Tuesday, 21 March 2023.
Analyst Presentation
A presentation for analysts will be held at 11:00am on Tuesday, 21 March 2023
via webinar. Analysts wishing to attend should register their interest in
advance with quixant@almapr.co.uk (mailto:quixant@almapr.co.uk) .
Investor Presentation
Jon Jayal, Chief Executive Officer, and Johan Olivier, Chief Financial
Officer, will provide a live presentation relating to the Group's results for
the year ended 31 December 2022 via the Investor Meet Company platform on 24
March 2023 at 11:00am. The presentation is open to all existing and potential
shareholders and registration can be completed via the following link:
https://www.investormeetcompany.com/quixant-plc/register-investor
(https://www.investormeetcompany.com/quixant-plc/register-investor)
Questions can be submitted pre-event via the Investor Meet Company dashboard
up until 9:00am the day before the meeting or at any time during the live
presentation.
Investors who already follow Quixant on the Investor Meet Company platform
will automatically be invited.
Quixant plc Tel: +44 (0)1223 892 696
Jon Jayal, Chief Executive Officer
Johan Olivier, Chief Financial Officer
Nominated Adviser and Broker: Tel: +44 (0) 20 7220 0500
finnCap Ltd
Matt Goode / Simon Hicks (Corporate Finance)
Alice Lane / Charlotte Sutcliffe (ECM)
Joint Broker: Tel: +44 (0) 20 7523 8000
Canaccord Genuity Limited
Simon Bridges / Andrew Potts
Financial PR: Tel: +44 (0)20 3405 0205
Alma PR
Hilary Buchanan / Kieran Breheny / Will Ellis Hancock
About Quixant
Quixant, founded in 2005, designs and manufactures highly optimised computing
solutions and monitors principally for the global gaming and broadcast
industries. The Company is headquartered in Cambridge in the UK, with offices
throughout Europe, North America and Asia. Quixant has its own manufacturing
and engineering operation based in Taiwan and software engineering and
customer support teams based in Italy and Slovenia. All the specialised
products software and manufacturing are produced in-house and Quixant owns all
its own IP some of which is protected by patents and design rights.
In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a
strong heritage in the sale of electronic display solutions to global
industrial markets. Through Densitron's experienced sales team, Quixant has a
robust platform to build its business into wider industrial markets. In-depth
information on the Company's products, markets, activities and history can be
found on the corporate website at www.quixant.com (http://www.quixant.com) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NORFLFEEFDIIFIV